Quoin Pharmaceuticals Ltd.
QNRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671502
In the last 90 days, Quoin Pharmaceuticals Ltd. insiders filed 4 open-market purchases and 0 sales; 19 institutions reported holding it in 13F filings for Q2 2026, worth $6.29M in total; no superinvestor holds it.
Holders of 5% or more of QNRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Quoin Pharmaceuticals Ltd., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Ikarian Capital, LLC | 13G/A | 12.60%211.5K shares | −12.60 ppfrom 25.20% | Dec 15, 20252 filings | Feb 6, 2026 | SEC |
| Stonepine Capital Management, LLC | 13G/A | 9.99%7.59M shares | −0.61 ppfrom 10.60% | Dec 16, 20253 filings | May 15, 2026 | SEC |
| Resolute Capital Asset Partners LLC | 13G | 8.50%50.0K shares | New | Dec 11, 20251 filing | Dec 11, 2025 | SEC |
| Integrated Core Strategies (US) LLC | 13G | 5.50%3.85M shares | +0.90 ppfrom 4.60% | Oct 27, 20253 filings | Jun 2, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
33 Schedule 13D and 13G filings on Quoin Pharmaceuticals Ltd., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 2, 20265:14 PM ET | Integrated Core Strategies (US) LLCand 3 others | 13G | 5.50%3.85M shares | +0.90 ppfrom 4.60% | May 26, 2026 | SEC |
| May 15, 20268:16 PM ET | ADAR1 Capital Management, LLCand 2 others | 13G/A | 4.90%102.9K shares | −2.00 ppfrom 6.90%Below 5% | Mar 31, 2026 | SEC |
| May 15, 20265:23 PM ET | Stonepine Capital Management, LLCand 3 others | 13G/A | 9.99%7.59M shares | −0.61 ppfrom 10.60% | Mar 31, 2026 | SEC |
| May 15, 20269:13 AM ET | Woodline Partners LP | 13G/A | 4.40%2.79M shares | −5.10 ppfrom 9.50%Below 5% | Mar 31, 2026 | SEC |
| Apr 29, 20266:41 AM ET | Standard Life Aberdeen plcand 1 other | 13G/A | 4.16%75.0K shares | −4.78 ppfrom 8.94%Below 5% | Apr 1, 2026 | SEC |
| Feb 17, 20268:14 PM ET | ADAR1 Capital Management, LLCand 2 others | 13G | 6.90%58.2K shares | New | Dec 31, 2025 | SEC |
| Feb 17, 20263:20 PM ET | Woodline Partners LP | 13G | 9.50%2.79M shares | New | Dec 31, 2025 | SEC |
| Feb 11, 20265:10 PM ET | Integrated Core Strategies (US) LLCand 3 others | 13G/A | 4.60%2.62M shares | −4.40 ppfrom 9.00%Below 5% | Dec 31, 2025 | SEC |
| Feb 6, 20265:28 PM ET | Ikarian Capital, LLCand 1 other | 13G/A | 12.60%211.5K shares | −12.60 ppfrom 25.20% | Jan 31, 2026 | SEC |
| Feb 2, 20268:01 PM ET | Stonepine Capital Management, LLCand 3 others | 13G/A | 10.60%3.27M shares | +0.70 ppfrom 9.90% | Jan 29, 2026 | SEC |
| Jan 28, 202611:05 AM ET | Standard Life Aberdeen plcand 1 other | 13G | 8.94%75.0K shares | New | Dec 31, 2025 | SEC |
| Dec 16, 20254:04 PM ET | Stonepine Capital Management, LLCand 3 others | 13G | 9.90%3.03M shares | New | Dec 10, 2025 | SEC |
| Dec 15, 20259:53 PM ET | Ikarian Capital, LLCand 1 other | 13G | 25.20%211.5K shares | New | Nov 30, 2025 | SEC |
| Dec 11, 202510:10 AM ET | Resolute Capital Asset Partners LLCand 1 other | 13G | 8.50%50.0K shares | New | Oct 10, 2025 | SEC |
| Oct 27, 20254:32 PM ET | Integrated Core Strategies (US) LLCand 3 others | 13G | 9.00%1.90M shares | New | Oct 20, 2025 | SEC |
| May 15, 20253:40 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%1.08M shares | −5.00 ppfrom 9.99%Below 5% | Mar 31, 2025 | SEC |
| Feb 14, 20254:54 PM ET | Armistice Capital, LLCand 1 other | 13G | 9.99%934.3K shares | New | Dec 31, 2024 | SEC |
| Jan 28, 20254:44 PM ET | Myers Michael | 13D/A | 4.90%939.2K shares | −2.00 ppfrom 6.90%Below 5% | Jan 27, 2025 | SEC |
| Jan 28, 20254:43 PM ET | Carter Denise P. | 13D/A | 4.90%939.2K shares | −2.00 ppfrom 6.90%Below 5% | Jan 27, 2025 | SEC |
| Jan 2, 20255:20 PM ET | Carter Denise P. | 13D | 6.90%622.4K shares | New | Dec 23, 2024 | SEC |
| Jan 2, 20255:20 PM ET | Myers Michael | 13D | 6.90%622.6K shares | New | Dec 23, 2024 | SEC |
| Nov 14, 2024 | Lind Global Fund II LP | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Lind Global Fund II LP | 13G/AOld format | – | – | – | SEC |
| Mar 3, 2023 | Lind Global Fund II LP | 13GOld format | – | New | – | SEC |
| Feb 14, 20232:40 PM ET | Goldman Sachs Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | CVI Investments, Inc. | 13G/AOld format | – | – | – | SEC |
| Aug 12, 2022 | CVI Investments, Inc. | 13GOld format | – | – | – | SEC |
| Mar 10, 20223:26 PM ET | Goldman Sachs Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Altium Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 10, 20224:32 PM ET | Goldman Sachs Group Inc | 13GOld format | – | New | – | SEC |
| Nov 12, 2021 | Altium Capital Management LP | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | CVI Investments, Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 13, 2021 | Empery Asset Management, LP | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Quoin Pharmaceuticals Ltd. shares.
No Form 144 notices for Quoin Pharmaceuticals Ltd. are on file.